Canagliflozin (Invokana, Invokamet): Drug Safety Communication - Clinical Trial Results Find Increased Risk of Leg and Foot Amputations

FDA is currently investigating this new safety issue. Patients should not stop or change their diabetes medicines.
Source: FDA MedWatch Safety Alert - Category: American Health Source Type: alerts